press releases

Press Releases

James R. Berenson MD, Inc. Receives 2019 Best of West Hollywood Award

West Hollywood Award Program Honors the Achievement

WEST HOLLYWOOD November 27, 2019 — James R. Berenson MD, Inc. has been selected for the 2019 Best of West Hollywood Award in the Doctors category by the West Hollywood Award Program. Each year, the West Hollywood Award Program identifies companies that we believe have achieved exceptional marketing success in their local community and business category. These are local companies that enhance the positive image of small business through service to their customers and our community. These exceptional companies help make the West Hollywood area a great place to live, work and play. Various sources of information were gathered and analyzed to choose the winners in each category. The 2019 West Hollywood Award Program focuses on quality, not quantity. Winners are determined based on the information gathered both internally by the West Hollywood Award Program and data provided by third parties.

About West Hollywood Award Program

The West Hollywood Award Program is an annual awards program honoring the achievements and accomplishments of local businesses throughout the West Hollywood area. Recognition is given to those companies that have shown the ability to use their best practices and implemented programs to generate competitive advantages and long-term value. The West Hollywood Award Program was established to recognize the best of local businesses in our community. Our organization works exclusively with local business owners, trade groups, professional associations and other business advertising and marketing groups. Our mission is to recognize the small business community’s contributions to the U.S. economy. SOURCE: West Hollywood Award Program

CONTACT:

West Hollywood Award Program
Email: PublicRelations@business-awardsinformation2019.com
URL: http://www.business-awardsinformation2019.com

Oncology CRO Oncotherapeutics Presents at ASH 2011 Annual Meeting Los Angeles, Nov 23, 2011 — Oncotherapeutics, an oncology specific Contract Research Organization (CRO) specializing in the oversight and management of clinical trials for cancer, will present final results from a multicenter clinical trial at the American Society of Hematology Annual Meeting in San Diego, California on December 10-13 , 2011.

Kyphon® Balloon Kyphoplasty Found Beneficial for Treating Spinal Fractures in Cancer Patients The results of this landmark study should be welcomed news to cancer patients across the world suffering from the debilitating effects of painful vertebral compression fractures,” said Dr. James Berenson, the study’s first author and Medical and Scientific Director of the Institute for Myeloma and Bone Cancer Research in Los Angeles, CA. “It is documented that nearly one-fourth (24 percent) of patients with multiple myeloma, 14 percent with breast cancer, 8 percent with lung cancer and 6 percent with prostate cancer suffer painful vertebral compression fractures. With the results of this new randomized study, there is now clinical evidence of a treatment option for spinal fractures in cancer patients that can provide excellent relief of pain and improved quality of life.”

Los Angeles Non Profit Cancer Research Institute Hosts Beverly Hills Art Reception Featuring Rare Collections of Picasso, Miro and Dali and Never Before Seen Photographs of Marilyn Monroe. Institute for Myeloma and Bone Cancer Research’s Fall Art Benefit offers an afternoon of art appreciation and auction, wine, and hors d’oeuvres at the Andrew Weiss Gallery in Beverly Hills, CA.

Institute for Myeloma and Bone Cancer Research in Los Angeles Proudly Announces Roger Townsend to join its Board of Directors as Treasurer. Roger Townsend makes the transition to IMBCR’s board of directors after serving two years on its Audit Committee.

Reunion Beer Kicks Off 2010 Fundraising Campaign With Release of Belgian-Style Scotch Ale REUNION – A Beer for Hope, now in its fourth year, today announced the release of its 2010 special brew, a Belgian-Style Scotch Ale.View pdf

Benefit Gala of “Cooking with Stella” to open the 8th annual Indian Film Festival Los Angeles IFFLA opening supports the work of the Institute for Myeloma & Bone Cancer Research

Variety Benefits IMBCR Indian Film Festival takes place in L.A. on April 20

Manhattan Beach Sun January 2010 Coordinating Council Hears Positive News from Dr Berenson

I-Newswire December 2009 Institute for Myeloma and Bone Cancer Research featured at American Society of Hematology 2009 CEO and founder, James R. Berenson, MD and IMBCR researchers will present the 9 papers, oral presentations and special sessions December 5-8, 2009 at the 51st ASH Annual Meeting and Exposition. Video Feature July 2009 Dr. Jim Berenson is featured on KTLA-Channel 5’s prime time news segment from Emmy award winning news anchor, Emmett Miller as he follows the story of a courageous young police officer who is battling multiple myeloma. https://www.youtube.com/v/Irc_uKcg3vc

January 2009 Institute for Myeloma and Bone Cancer Research in Los Angeles Proudly Announces that Ethan Horwitz, Esq of King & Spalding Law Firm has joined its Board of Directors.

February 2009Researchers Identify Novel Mechanism That Make Cancer Tumors Grow Scientists at the Institute for Myeloma and Bone Cancer Research (IMBCR) have uncovered a new pathway that could explain how blood vessels form within tumors. January 2009 – One Million Dollars awarded to Institute for Myeloma and Bone Cancer Research FJC, a New York-based donor advised fund, is the latest organization to grant major funding to the “Cure Myeloma Project”, an ongoing research initiative at the Institute for Myeloma and Bone Cancer Research, (IMBCR), in Los Angeles, CA

Press ReleaseDecember 2008 Myeloma Research Fund Grants Institute for Myeloma and Bone Cancer Research an additional $200,000 for “Cure Myeloma Project”. Part of the Institute for Myeloma and Bone Cancer Research (IMBCR) “Cure Myeloma Project”, this funding will further explore new targeted therapeutic approaches against Multiple Myeloma with hopes of creating groundbreaking new treatments against malignant myeloma cells and devastating bone loss.

Press Release November 2008 Institute for Myeloma and Bone Cancer Research Announces Upcoming Oral and Poster Presentations at the 2008 American Society of Hematology (ASH) Annual Meeting Two oral presentations and three poster presentations will be offered by researchers from the Institute for Myeloma and Bone Cancer Research celebrating the 50th Annual Meeting of the American Society of Hematology (ASH). More Information…

Press Release June 2008 Multiple Myeloma Expert Featured on XM Satellite Radio Myeloma Specialist Dr. James R. Berenson Featured on ReachMD’s “Clinician’s Roundtable” Read the Article…

XM Satellite Radio June 2008 Dr. Berenson featured on ReachMD XM Satellite Radio Channel 157 “Multiple Myeloma: Current Treatment Modalities” Free registration required.

I-Newswire.com Multiple Myeloma expert, James R. Berenson, MD, featured on free telephone workshop, “Caring for Your Bones When You Have Multiple Myeloma” April 2, 2008.

I-Newswire.comFebruary 2008 The Institute for Myeloma and Bone Cancer Research announces Roger Fischer and Alvin Dischler have been appointed to its Board of Directors.

I-Newswire.comFebruary 2008 “Ask the Expert” Launched (I-Newswire) – Los Angeles, CA – MMSupport.net and the Institute for Myeloma and Bone Cancer Research are proud to announce the creation of “Ask the Expert”, a free online web-forum featuring Multiple Myeloma expert, Dr. James R. Berenson.

I-Newswire.comJanuary 2008 The Institute for Myeloma and Bone Cancer Research announces the addition of Zhi-Wei Li, Ph.D. as Principal Scientist for “The Cure Myeloma Project” Zhi-Wei Li, Ph.D. formerly of The Moffitt Cancer Research Center affiliated with the University of South Florida will lead scientific efforts for the Institute of Myeloma and Bone Cancer Research’s most recent research initiative, “The Cure Myeloma Project.”

Patientpower.comNovember 2007 Contemporary Issues in Relapsed-Refractory Myeloma We’ve been receiving hundreds of questions from myeloma patients. While we can’t answer them all, they do tend to cover common ground. We’ll address key topics in our next live webcast, the fourth in a series of 7 programs. Join us for our discussion with Dr. James Berenson, Founder, President and CEO of the Institute for Myeloma and Bone Cancer Research. Replay Available here .

Coping with Cancer May/June 2007 New Developments in Multiple Myeloma Management Positive results from numerous clinical trials have led to a rapid increase in the therapeutic options now available to effective care for people with multiple myeloma